Eli Lilly and Company· @EliLillyandCo · X·· 2026-06-25精选AI 评分62
AI 导读
礼来宣布，Medicare 针对肥胖治疗的新获取通道将于7月1日启动，符合条件的 Medicare Part D 患者可通过 Medicare GLP-1 Bridge 获得部分体重管理药物。礼来同时提供了 CMS 的 Medicare GLP-1 Bridge 临床标准链接供查询。
推荐理由
礼来官方说明 Medicare Part D 患者自7月1日起可经 GLP-1 Bridge 获取减重药物，并附 CMS 临床标准链接。
正文
A new pathway for access to obesity treatment through Medicare begins July 1. Eligible Medicare Part D patients may be able to get certain medicines for weight management through Medicare GLP-1 Bridge.
Learn more and see the CMS Medicare GLP-1 Bridge Clinical Criteria: https://go.lilly.com/ivxgk3
来源：Eli Lilly and Company · x.com